Development of resistance to BET bromodomain inhibitor JQ1 and demonstration in epithelial-mesenchymal transition in pancreatic cancer cells.

被引：0
|
作者：
Raza, Sania S.
Knab, Mark
Chow, Christina
Kumar, Krishan
Ebine, Kazumi
Munshi, Hidayatullah G.
机构：
[1] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[2] Northwestern Univ, Chicago, IL 60611 USA
[3] Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.e15263
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15263
引用
收藏
页数：1
相关论文
共 50 条
  • [21] BET protein inhibitor JQ1 inhibits growth and modulates WNT signaling in mesenchymal stem cells
    Saeed Alghamdi
    Irfan Khan
    Naimisha Beeravolu
    Christina McKee
    Bryan Thibodeau
    George Wilson
    G. Rasul Chaudhry
    Stem Cell Research & Therapy, 7
  • [22] The bromodomain inhibitor JQ1 enhances cisplatin-mediated cytotoxicity in ovarian cancer cells
    Khabele, Dineo
    Wilson, Andrew J.
    Saskowski, Jeanette
    Hiebert, Scott W.
    CLINICAL CANCER RESEARCH, 2013, 19
  • [23] BET protein inhibitor JQ1 inhibits growth and modulates WNT signaling in mesenchymal stem cells
    Alghamdi, Saeed
    Khan, Irfan
    Beeravolu, Naimisha
    McKee, Christina
    Thibodeau, Bryan
    Wilson, George
    Chaudhry, G. Rasul
    STEM CELL RESEARCH & THERAPY, 2016, 7
  • [24] The BET bromodomain inhibitor JQ1 suppresses cancer cell growth in naive and sunitinib resistant renal cell carcinoma
    Sakaguchi, Takashi
    Yoshino, Hirofumi
    Sugita, Satoshi
    Osako, Youichi
    Yonemori, Masaya
    Miyamoto, Kazutaka
    Enokida, Hideki
    Nakagawa, Masayuki
    CANCER SCIENCE, 2018, 109 : 336 - 336
  • [25] JQ1, a BET-bromodomain inhibitor, inhibits human cancer growth and suppresses PD-L1 expression
    Liu, Kaisheng
    Zhou, Zhifan
    Gao, Hengyuan
    Yang, Fang
    Qian, Yajun
    Jin, Hongtao
    Guo, Yaomin
    Liu, Ying
    Li, Haili
    Zhang, Cheng
    Guo, Jinan
    Wan, Yong
    Chen, Rui
    CELL BIOLOGY INTERNATIONAL, 2019, 43 (06) : 642 - 650
  • [26] The bromodomain inhibitor JQ1 sensitizes homologous recombination proficient ovarian cancer cells to the PARP inhibitor olaparib
    Wilson, Andrew J.
    Thompson, Janese
    Osman, Abdirahman
    Saskowski, Jeanette
    Khabele, Dineo
    CANCER RESEARCH, 2017, 77
  • [27] BET bromodomain inhibitor JQ1 promotes immunogenic cell death in tongue squamous cell carcinoma
    Wang, Miao
    Zhao, Lu
    Tong, Dongdong
    Yane, Linrui
    Zhu, Hongjie
    Li, Qing
    Zhang, Fenghe
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, 76
  • [28] Nitric oxide antagonism to glioblastoma photodynamic therapy and mitigation thereof by BET bromodomain inhibitor JQ1
    Fahey, Jonathan M.
    Stancill, Jennifer S.
    Smith, Brian C.
    Girotti, Albert W.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2018, 293 (14) : 5345 - 5359
  • [29] Akt/mTOR-Mediated Autophagy Confers Resistance To BET Inhibitor JQ1 In Ovarian Cancer
    Luan, Wenqing
    Pang, Yingxin
    Li, Rui
    Wei, Xuan
    Jiao, Xiaoxiao
    Shi, Juanjuan
    Yu, Jiangtao
    Mao, Hongluan
    Liu, Peishu
    ONCOTARGETS AND THERAPY, 2019, 12 : 8063 - 8074
  • [30] Pancreatic stellate cells promote epithelial-mesenchymal transition in pancreatic cancer cells
    Kikuta, Kazuhiro
    Masamune, Atsushi
    Watanabe, Takashi
    Ariga, Hiroyuki
    Itoh, Hiromichi
    Hamada, Shin
    Satoh, Kennichi
    Egawa, Shinichi
    Unno, Michiaki
    Shimosegawa, Tooru
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 403 (3-4) : 380 - 384
12345